Ligand Pharmaceuticals Incorporated (LGND) Insider Trading
- $6,495,870.39
- $219,394,361.93
- June 23, 2025
- John L Higgins
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 23, 2025 | Insider | 500 | $114.08 | Sell | $57,040.00 | |
June 10, 2025 | Insider | 500 | $114.54 | Sell | $57,270.00 | |
May 9, 2025 | CEO | 9,510 | $105.20 | Buy | $1,000,452.00 | |
May 9, 2025 | CFO | 1,500 | $104.06 | Buy | $156,090.00 | |
March 4, 2025 | CFO | 5,000 | $115.03 | Sell | $575,150.00 | |
Dec. 23, 2024 | CFO | 2,104 | $116.37 | Sell | $244,842.48 | |
Nov. 27, 2024 | Director | 2,406 | $123.65 | Sell | $297,501.90 | |
Sept. 23, 2024 | Insider | 2,000 | $99.60 | Sell | $199,200.00 | |
Sept. 23, 2024 | COO | 9,772 | $101.22 | Sell | $989,121.84 | |
Sept. 20, 2024 | COO | 6,275 | $104.10 | Sell | $653,227.50 | |
Sept. 20, 2024 | CFO | 1,275 | $103.94 | Sell | $132,523.50 | |
Aug. 28, 2024 | Insider | 1,500 | $106.39 | Sell | $159,585.00 | |
Aug. 26, 2024 | COO | 11,389 | $105.61 | Sell | $1,202,792.29 | |
Aug. 22, 2024 | COO | 1,157 | $105.54 | Sell | $122,109.78 | |
Aug. 9, 2024 | COO | 18,245 | $98.50 | Sell | $1,797,132.50 | |
Aug. 8, 2024 | CEO | 2,500 | $97.39 | Buy | $243,475.00 | |
May 17, 2024 | CFO | 5,156 | $86.66 | Sell | $446,818.96 | |
May 15, 2024 | CFO | 5,873 | $86.01 | Sell | $505,136.73 | |
May 13, 2024 | Insider | 3,440 | $84.54 | Sell | $290,817.60 | |
May 9, 2024 | Insider | 10,000 | $83.04 | Sell | $830,400.00 | |
March 5, 2024 | Director | 1,893 | $74.30 | Sell | $140,649.90 | |
Feb. 28, 2024 | CFO | 140 | $88.46 | Sell | $12,384.40 | |
Sept. 22, 2023 | CEO | 4,000 | $59.38 | Buy | $237,520.00 | |
May 16, 2023 | Director | 4,444 | $77.20 | Sell | $343,076.80 | |
May 10, 2023 | Director | 6,408 | $77.13 | Sell | $494,249.04 | |
May 8, 2023 | Director | 6,408 | $76.56 | Sell | $490,596.48 | |
March 24, 2023 | Insider | 300 | $69.92 | Sell | $20,976.00 | |
Dec. 16, 2022 | Director | 10,000 | $61.87 | Sell | $618,700.00 | |
Nov. 17, 2022 | CEO | 10,000 | $78.32 | Sell | $783,200.00 | |
Nov. 9, 2022 | CFO | 1,696 | $75.64 | Sell | $128,285.44 | |
Sept. 15, 2022 | CEO | 2,000 | $90.00 | Sell | $180,000.00 | |
May 13, 2022 | COO | 2,500 | $82.76 | Buy | $206,900.00 | |
Feb. 28, 2022 | Director | 908 | $102.62 | Sell | $93,178.96 | |
Nov. 12, 2021 | CEO | 3,000 | $160.50 | Sell | $481,500.00 | |
Nov. 11, 2021 | COO | 11,160 | $163.02 | Sell | $1,819,303.20 | |
Aug. 4, 2021 | COO | 8,840 | $109.67 | Sell | $969,482.80 | |
Feb. 10, 2021 | Director | 5,083 | $213.14 | Sell | $1,083,390.62 | |
Feb. 4, 2021 | SVP | 18,097 | $178.50 | Sell | $3,230,314.50 | |
Feb. 4, 2021 | COO | 44,547 | $176.86 | Sell | $7,878,582.42 | |
Jan. 27, 2021 | CEO | 40,000 | $182.00 | Sell | $7,280,000.00 | |
Jan. 25, 2021 | CEO | 50,000 | $159.00 | Sell | $7,950,000.00 | |
Aug. 24, 2020 | COO | 78 | $110.89 | Sell | $8,649.42 | |
Aug. 21, 2020 | COO | 7,225 | $112.88 | Sell | $815,558.00 | |
June 4, 2020 | SVP | 11,146 | $118.59 | Sell | $1,321,804.14 | |
Feb. 27, 2020 | COO | 7,225 | $14.47 | Buy | $104,545.75 | |
Feb. 27, 2020 | COO | 1,706 | $21.92 | Buy | $37,395.52 | |
Feb. 27, 2020 | COO | 7,225 | $110.00 | Sell | $794,750.00 | |
Feb. 15, 2020 | COO | 869 | $97.23 | Sell | $84,492.87 | |
Feb. 15, 2020 | COO | 447 | $97.23 | Sell | $43,461.81 | |
Feb. 15, 2020 | COO | 1,170 | $97.23 | Sell | $113,759.10 |
Insiders are both buying and selling Ligand Pharmaceuticals Incorporated stock.
The insider traders at Ligand Pharmaceuticals Incorporated are: Matthew W Foehr, John L Higgins, Jason Aryeh, John W Kozarich, Octavio Espinoza, Charles S Berkman, Matthew E Korenberg, Todd C Davis, Andrew Reardon, Stephen L Sabba, Bvf Partners L P/Il, John L Lamattina, David M Knott, Melanie J Herman, Bvf Partners P/Il, Nishan M Desilva, Sunil Patel, David Knott, Matthew Foehr, Charles Berkman, John Sharp, Todd Davis, John Higgins, John W. Kozarich, Melanie J. Herman, and John Lamattina
The most active insider trader at Ligand Pharmaceuticals Incorporated is Matthew W Foehr with 27 trades.
Bvf Partners P/Il has sold the most Ligand Pharmaceuticals Incorporated stock with a total value of $58,156,493.18.
Bvf Partners L P/Il has bought the most Ligand Pharmaceuticals Incorporated stock with a total value of $2,817,728.47.
The most recent insider trade for Ligand Pharmaceuticals Incorporated was on June 23, 2025.
The single biggest insider buy for Ligand Pharmaceuticals Incorporated was from Todd C Davis with a total value of $1,000,452.00 on May 9, 2025.
The single biggest insider sell for Ligand Pharmaceuticals Incorporated was from Bvf Partners P/Il with a total value of $31,214,249.00 on Feb. 20, 2014.